The higher incidence of breast cancer in the biobank population was likely a reflection of frequency of care and age; however, in our risk analysis, we used the biobank patients without evidence of BRCA1/2 variants as the control population, which mitigated this bias. Here, BRCA1 is linked to breast cancer.